Literature DB >> 8350054

I-E+ nonobese diabetic mice develop insulitis and diabetes.

P L Podolin1, A Pressey, N H DeLarato, P A Fischer, L B Peterson, L S Wicker.   

Abstract

The development of type I diabetes in the nonobese diabetic (NOD) mouse is under the control of multiple genes, one or more of which is linked to the major histocompatibility complex (MHC). The MHC class II region has been implicated in disease development, with expression of an I-E transgene in NOD mice shown to provide protection from insulitis and diabetes. To examine the effect of expressing an I-E+ or I-E- non-NOD MHC on the NOD background, three I-E+ and three I-E- NOD MHC congenic strains (NOD.H-2i5, NOD.H-2k, and NOD.H-2h2, and NOD.H-2h4, NOD.H-2i7, and NOD.H-2b, respectively) were developed. Of these strains, both I-E+ NOD.H-2h2 and I-E- NOD.H-2h4 mice developed insulitis, but not diabetes. The remaining four congenic strains were free of insulitis and diabetes. These results indicate that in the absence of the NOD MHC, diabetes fails to develop. Each NOD MHC congenic strain was crossed with the NOD strain to produce I-E+ and I-E- F1 mice; these mice thus expressed one dose of the NOD MHC and one dose of a non-NOD MHC on the NOD background. While a single dose of a non-NOD MHC provided a large degree of disease protection to all of the F1 strains, a proportion of I-E+ and I-E- F1 mice aged 5-12 mo developed insulitis and cyclophosphamide-induced diabetes. When I-E+ F1 mice were aged 9-17 mo, spontaneous diabetes developed as well. These data are the first to demonstrate that I-E+ NOD mice develop diabetes, indicating that expression of I-E in NOD mice is not in itself sufficient to prevent insulitis or diabetes. In fact, I-E- F1 strains were no more protected from diabetes than I-E+ F1 strains, suggesting that other non-NOD MHC-linked genes are important in protection from disease. Finally, transfer of NOD bone marrow into irradiated I-E+ F1 recipients resulted in high incidences of diabetes, indicating that expression of non-NOD MHC products in the thymus, in the absence of expression in bone marrow-derived cells, is not sufficient to provide protection from diabetes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350054      PMCID: PMC2191185          DOI: 10.1084/jem.178.3.793

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

Review 1.  Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

Authors:  L Castaño; G S Eisenbarth
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes.

Authors:  A G Ziegler; P Vardi; A T Ricker; M Hattori; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1989-03       Impact factor: 9.461

3.  MHC-linked protection from diabetes dissociated from clonal deletion of T cells.

Authors:  J Böhme; B Schuhbaur; O Kanagawa; C Benoist; D Mathis
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

4.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.

Authors:  T Miyazaki; M Uno; M Uehira; H Kikutani; T Kishimoto; M Kimoto; H Nishimoto; J Miyazaki; K Yamamura
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

5.  Anti-islet cell antibodies from NOD mice.

Authors:  P Supon; P Stecha; K Haskins
Journal:  Diabetes       Date:  1990-11       Impact factor: 9.461

Review 6.  A unified hypothesis for the complex genetics of HLA associations with IDDM.

Authors:  G T Nepom
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

7.  Raised temperature reduces the incidence of diabetes in the NOD mouse.

Authors:  A J Williams; J Krug; E F Lampeter; K Mansfield; P E Beales; A Signore; E A Gale; P Pozzilli
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

8.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.

Authors:  T Lund; L O'Reilly; P Hutchings; O Kanagawa; E Simpson; R Gravely; P Chandler; J Dyson; J K Picard; A Edwards
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

9.  Genetic control of diabetes and insulitis in the nonobese diabetic mouse. Pedigree analysis of a diabetic H-2nod/b heterozygote.

Authors:  L S Wicker; B J Miller; P A Fischer; A Pressey; L B Peterson
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

10.  Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.

Authors:  R M Slattery; L Kjer-Nielsen; J Allison; B Charlton; T E Mandel; J F Miller
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

View more
  44 in total

1.  A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes.

Authors:  Stephen T Ferris; Javier A Carrero; James F Mohan; Boris Calderon; Kenneth M Murphy; Emil R Unanue
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  Increased thyroidal fat and goitrous hypothyroidism induced by interferon-gamma.

Authors:  Hiroaki Kimura; Miho Kimura; William H Westra; Noel R Rose; Patrizio Caturegli
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

Review 3.  Sjögren syndrome: advances in the pathogenesis from animal models.

Authors:  J A Chiorini; D Cihakova; C E Ouellette; P Caturegli
Journal:  J Autoimmun       Date:  2009-10-02       Impact factor: 7.094

4.  MicroRNA-326 contributes to autoimmune thyroiditis by targeting the Ets-1 protein.

Authors:  Na Zhao; Hongjin Zou; Jing Qin; Chenling Fan; Yongping Liu; Shuo Wang; Zhongyan Shan; Weiping Teng; Yushu Li
Journal:  Endocrine       Date:  2017-11-27       Impact factor: 3.633

5.  Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice.

Authors:  Sandra M McLachlan; Holly A Aliesky; Basil Rapoport
Journal:  J Immunol       Date:  2019-04-03       Impact factor: 5.422

6.  Regulatory T cells in B-cell-deficient and wild-type mice differ functionally and in expression of cell surface markers.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

7.  Autoimmune manifestations in aged mice arise from early-life immune dysregulation.

Authors:  Tamer I Mahmoud; Jingya Wang; Jodi L Karnell; Qiming Wang; Shu Wang; Brian Naiman; Phillip Gross; Philip Z Brohawn; Chris Morehouse; Jordan Aoyama; Clive Wasserfall; Laura Carter; Mark A Atkinson; David V Serreze; Helen Braley-Mullen; Tomas Mustelin; Roland Kolbeck; Ronald Herbst; Rachel Ettinger
Journal:  Sci Transl Med       Date:  2016-10-19       Impact factor: 17.956

8.  High salt intake does not exacerbate murine autoimmune thyroiditis.

Authors:  P Kolypetri; E Randell; B N Van Vliet; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

9.  Reduced effectiveness of CD4+Foxp3+ regulatory T cells in CD28-deficient NOD.H-2h4 mice leads to increased severity of spontaneous autoimmune thyroiditis.

Authors:  Jason S Ellis; So-Hee Hong; Habib Zaghouani; Helen Braley-Mullen
Journal:  J Immunol       Date:  2013-10-04       Impact factor: 5.422

10.  Cutting edge: genetic characterization of IFN-producing killer dendritic cells.

Authors:  Fanny Guimont-Desrochers; Zachary John Cappello; Miguel Chagnon; Marcia McDuffie; Sylvie Lesage
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.